Search for: "Wyeth Pharmaceuticals Company, Inc." Results 61 - 80 of 282
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Apr 2013, 2:43 pm by Fraud Fighters
Abbott Laboratories Inc. agreed to pay $1.5 billion in order to resolve criminal and civil allegations surrounding the company’s off-label marketing of Depakote. [read post]
5 Apr 2013, 1:01 pm by Bexis
Wyeth, Inc., 2012 WL 79670, at *7 (W.D.N.C. [read post]
2 Apr 2013, 10:33 am by Anubha Sinha
Wyeth Ltd. to consider as to what amounts to ‘prior publication’ under the Design Act, 2000 in this post. [read post]
1 Mar 2013, 2:30 pm by Bexis
McNeil-PPC, Inc., 2009 WL 1178651, at *3-4 (Pa. [read post]
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
District Court for the District of New Jersey concerning Wyeth Pharmaceuticals Inc. [read post]
9 Aug 2012, 11:29 am by N. Peter Rasmussen
The SEC separately charged another pharmaceutical company that Pfizer acquired in 2009, Wyeth LLC, with additional FCPA violations.Pfizer and Wyeth agreed to separate settlements in which they will pay more than $45 million combined to settle their respective charges. [read post]
7 Aug 2012, 12:54 pm by Robert J. Tannous
The SEC filed a separate Complaint charging another pharmaceutical company that Pfizer acquired several years ago – Wyeth LLC – with its own FCPA violations. [read post]
7 Aug 2012, 10:11 am by Mike Scarcella
The SEC separately charged Wyeth LLC—Pfizer purchased the company in 2009—with violations of the Foreign Corrupt Practices Act. [read post]
2 Aug 2012, 10:17 am by FDABlog HPM
May 2, 2012) denying Mutual Pharmaceutical Company’s (“Mutual’s”) appeal of a decision from the U.S. [read post]